CPES

"Flexibility and Choice for Consumers and Their Families"

Welcome to our Website


    Arizona 2-1-1
    Behavioral Consultation
    Community Assistance
      - ACDL
      - ALTCS
      - Food Banks
      - DES/DDD Offices
      - DES/DDD Overview
      - DES/DDD Navigating
        the Systems
      - DES/DDD Trust Fund
      - HUD Housing
      - Medicare/Medicaid
      - SSI Help
    Legislative Information
      - Bills in Session
      - Contact Your Rep
      - Governor's Council
    Medication Information
      - Common Medications
      - Drugs & Medicines
      - Side Effects
      - Tardive Dyskinesia
    National Website Listings
    Neurological Disorders
    Publications
    Self-Advocacy/
         Customer Choice
      - AzEIP
      - CSD
      - CSD
      - EAPN
      - NASDDDS/"QualityMall"
      - NSDPO
      - OASIS
      - People First
      - The Arc
      - Through the
         Looking Glass
      - Other Groups
    Tips and Hints (FAQs)
    Volunteering

Medications

Tardive Dyskinesia

What is Tardive Dyskinesia?
Tardive dyskinesia is a neurological syndrome caused by the long-term use of neuroleptic drugs. Neuroleptic drugs are generally prescribed for psychiatric disorders, as well as for some gastrointestinal and neurological disorders. Tardive dyskinesia is characterized by repetitive, involuntary, purposeless movements. Features of the disorder may include grimacing, tongue protrusion, lip smacking, puckering and pursing, and rapid eye blinking. Rapid movements of the arms, legs, and trunk may also occur. Impaired movements of the fingers may appear as though the patient is playing an invisible guitar or piano.

Is there any treatment?
There is no standard treatment for tardive dyskinesia. Treatment is highly individualized. The first step is generally to stop or minimize the use of the neuroleptic drug. However, for patients with a severe underlying condition this may not be a feasible option. Replacing the neuroleptic drug with substitute drugs may help some patients. Other drugs such as benzodiazepines, adrenergic antagonists, and dopamine agonists may also be beneficial.

What is the prognosis?
Symptoms of tardive dyskinesia may remain long after discontinuation of neuroleptic drugs; however, with careful management, some symptoms may improve and/or disappear with time.

What research is being done?
The NINDS conducts and supports a broad range of research on movement disorders including tardive dyskinesia. The goals of this research are to improve understanding of these disorders and to discover ways to treat, prevent, and, ultimately, cure them.

 


 

Organizations

National Institute of Mental Health (NIMH)
6001 Executive Blvd.
Rm. 8184, MSC 9663
Bethesda, MD 20892-9663
Email: nimhinfo@nih.gov
Web: http://www.nimh.nih.gov
Tel: 301-443-4513
TTY: 301-443-8431
Depression Info: 800-421-4211
Anxiety Info:
   88-88-ANXIETY (888-269-4389)
Panic Info:
   888-64-PANIC (647-2642)
Fax: 301-443-4279

National Organization for Rare Disorders (NORD)
P.O. Box 8923
(100 Route 37)
New Fairfield, CT 06812-8923
Email: orphan@rarediseases.org
Web: http://www.rarediseases.org
Tel: 203-746-6518
   800-999-NORD (6673)
Fax: 203-746-6481

Tardive Dyskinesia/ Tardive Dystonia National Association
P.O. Box 45732
Seattle, WA 98145-0732
skjaer@halcyon.com
Tel: 206-522-3166
Fax: 206-528-2117